Clinical Trial Update: Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis [NA]

View source ↗

Summary

Open-label study evaluating maintenance dosing of etanercept in obese patients with moderate to severe plaque psoriasis; results were posted on 2013-05-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: University of California, San Francisco | Conditions: Psoriasis | NA | Status: COMPLETED | Results posted: 2013-05-07